Literature DB >> 10843164

Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome.

K J Mather1, S Verma, B Corenblum, T J Anderson.   

Abstract

Women with the polycystic ovarian syndrome (PCOS) carry a number of cardiovascular risk factors, including insulin resistance, lipid abnormalities, and an altered pattern of sex steroid exposure. Noninvasive measurements of endothelial function, which can demonstrate abnormalities well in advance of clinically apparent disease, have not been previously reported in this patient group. We undertook a cross-sectional evaluation of endothelium-dependent and -independent vascular function using brachial artery ultrasound. We studied healthy women with clinical and laboratory evidence of PCOS (n = 18) and age-matched controls (n = 19), not taking any antihypertensive, cholesterol-lowering, or hormonal therapies. Laboratory parameters of insulin resistance, glycemia, cholesterol status, and hormone levels were also measured. Despite marked differences in glucose/insulin ratio [6.1 +/- 1.1 mmol/pmol (PCOS) vs. 9.9 +/- 0.6 (controls)] and free androgen index [11.9 +/- 2.3 (PCOS) vs. 3.7 +/- 0.6 (controls); normal, <5], we did not find evidence of impaired endothelial function in our patients with PCOS. Both endothelium-dependent (8.7 +/- 3.1%) and endothelium-independent (23.2 +/- 3.4%) vascular responses were normal, and practically identical to the responses seen in the control group (endothelium-dependent, 9.0 +/- 0.7; endothelium-independent, 23.0 +/- 1.2%). The PCOS women were more obese, but baseline brachial arterial diameters were not different between groups. There was no correlation between degree of insulin resistance or hyperandrogenism and the brachial response. This group of healthy obese young women with insulin resistance and hyperandrogenism due to PCOS had normal endothelium-dependent and -independent vascular responses compared to age-matched controls. The factors resulting in preservation of these response are unclear and warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843164     DOI: 10.1210/jcem.85.5.6587

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes.

Authors:  A Enrique Caballero
Journal:  Curr Diab Rep       Date:  2004-08       Impact factor: 4.810

Review 2.  [Polycystic ovary syndrome. Prototype of a cardio-metabolic syndrome].

Authors:  D Heutling; H Schulz; H Randeva; C Dodt; H Lehnert
Journal:  Internist (Berl)       Date:  2007-02       Impact factor: 0.743

3.  Varying patterns of brachial artery flow-mediated dilatation in women with polycystic ovary syndrome and controls: An application of the group-based trajectory modeling.

Authors:  Michelle L Meyer; Ping G Tepper; Emma Barinas-Mitchell; Mary T Korytkowski; Evelyn O Talbott
Journal:  J Clin Ultrasound       Date:  2015-07-14       Impact factor: 0.910

Review 4.  Cardiometabolic aspects of the polycystic ovary syndrome.

Authors:  Harpal S Randeva; Bee K Tan; Martin O Weickert; Konstantinos Lois; John E Nestler; Naveed Sattar; Hendrik Lehnert
Journal:  Endocr Rev       Date:  2012-07-24       Impact factor: 19.871

Review 5.  Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS.

Authors:  H J Teede; S Hutchison; S Zoungas; C Meyer
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

6.  Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome.

Authors:  Megan M Wenner; Hugh S Taylor; Nina S Stachenfeld
Journal:  J Physiol       Date:  2011-08-08       Impact factor: 5.182

7.  Cardiovascular risk in women with polycystic ovarian syndrome (PCOS).

Authors:  A S T Bickerton; N Clark; D Meeking; K M Shaw; M Crook; P Lumb; C Turner; M H Cummings
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

Review 8.  Cardiovascular complications of obesity in adolescents.

Authors:  F Orio; S Palomba; T Cascella; S Savastano; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  2007-01       Impact factor: 4.256

9.  Hemodynamic alterations and wall properties in large arteries of young, normotensive, and non-obese women with polycystic ovary syndrome.

Authors:  E Trakakis; A Balanika; C Baltas; C Loghis; G Simeonidis; V Vaggopoulos; O Papakonstantinou; A Gouliamos; G Salamalekis; D Kassanos
Journal:  J Endocrinol Invest       Date:  2008-11       Impact factor: 4.256

Review 10.  Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.

Authors:  Krystallenia I Alexandraki; Eleni A Kandaraki; Kalliopi-Anna Poulia; Christina Piperi; Eirini Papadimitriou; Theodoros G Papaioannou
Journal:  touchREV Endocrinol       Date:  2021-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.